193 related articles for article (PubMed ID: 15057264)
1. Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide.
Argnani R; Boccafogli L; Marconi PC; Manservigi R
Gene Ther; 2004 Jul; 11(13):1087-98. PubMed ID: 15057264
[TBL] [Abstract][Full Text] [Related]
2. Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins.
Kouvatsis V; Argnani R; Tsitoura E; Arsenakis M; Georgopoulou U; Mavromara P; Manservigi R
Virus Res; 2007 Jan; 123(1):40-9. PubMed ID: 16989918
[TBL] [Abstract][Full Text] [Related]
3. Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells.
Laquerre S; Anderson DB; Stolz DB; Glorioso JC
J Virol; 1998 Dec; 72(12):9683-97. PubMed ID: 9811702
[TBL] [Abstract][Full Text] [Related]
4. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism.
Gerber SI; Belval BJ; Herold BC
Virology; 1995 Dec; 214(1):29-39. PubMed ID: 8525631
[TBL] [Abstract][Full Text] [Related]
5. Redirecting retroviral tropism by insertion of hepatitis B virus PreS1 core peptide into the envelope.
Qi P; Han JX; Lu YQ; Wang CX
Arch Virol; 2007; 152(9):1721-30. PubMed ID: 17520321
[TBL] [Abstract][Full Text] [Related]
6. Expression and characterization of hepatitis C Virus E2 glycoprotein fused to hepatitis B virus preS1(21-47) fragment in CHO cells.
Wang CL; Zhu LX; Liu J; Zhang ZC; Wang Y; Li GD
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jul; 34(4):400-4. PubMed ID: 12098759
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus 1 recombinant virions exhibiting the amino terminal fragment of urokinase-type plasminogen activator can enter cells via the cognate receptor.
Kamiyama H; Zhou G; Roizman B
Gene Ther; 2006 Apr; 13(7):621-9. PubMed ID: 16292350
[TBL] [Abstract][Full Text] [Related]
8. Targeting human glioma cells using HSV-1 amplicon peptide display vector.
Ho IA; Miao L; Sia KC; Wang GY; Hui KM; Lam PY
Gene Ther; 2010 Feb; 17(2):250-60. PubMed ID: 19812609
[TBL] [Abstract][Full Text] [Related]
9. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
Rux AH; Lou H; Lambris JD; Friedman HM; Eisenberg RJ; Cohen GH
Virology; 2002 Mar; 294(2):324-32. PubMed ID: 12009874
[TBL] [Abstract][Full Text] [Related]
10. Display of hepatitis B virus PreS1 peptide on bacteriophage T7 and its potential in gene delivery into HepG2 cells.
Tang KH; Yusoff K; Tan WS
J Virol Methods; 2009 Aug; 159(2):194-9. PubMed ID: 19490973
[TBL] [Abstract][Full Text] [Related]
11. Targeting HSV amplicon vectors.
Grandi P; Spear M; Breakefield XO; Wang S
Methods; 2004 Jun; 33(2):179-86. PubMed ID: 15121173
[TBL] [Abstract][Full Text] [Related]
12. A C-terminal PreS1 sequence is sufficient to retain hepatitis B virus L protein in 293 cells.
Gallina A; Gazina E; Milanesi G
Virology; 1995 Oct; 213(1):57-69. PubMed ID: 7483279
[TBL] [Abstract][Full Text] [Related]
13. Modified entry and syncytium formation by herpes simplex virus type 1 mutants selected for resistance to heparin inhibition.
Pertel PE; Spear PG
Virology; 1996 Dec; 226(1):22-33. PubMed ID: 8941319
[TBL] [Abstract][Full Text] [Related]
14. Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity.
Roller DG; Dollery SJ; Doyle JL; Nicola AV
Virology; 2008 Dec; 382(2):207-16. PubMed ID: 18950828
[TBL] [Abstract][Full Text] [Related]
15. Characterization of glycoprotein C of HSZP strain of herpes simplex virus 1.
Oravcová I; Kúdelová M; Mlcuchová J; Matis J; Bystrická M; Westra DF; Welling-Wester S; Rajcáni J
Acta Virol; 2000 Apr; 44(2):99-108. PubMed ID: 10989701
[TBL] [Abstract][Full Text] [Related]
16. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.
Maeng CY; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ
Virology; 2000 Apr; 270(1):9-16. PubMed ID: 10772975
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional features of the polycationic peptide required for inhibition of herpes simplex virus invasion of cells.
Trybala E; Olofsson S; Mårdberg K; Svennerholm B; Umemoto K; Glorioso JC; Bergström T
Antiviral Res; 2004 Jun; 62(3):125-34. PubMed ID: 15130536
[TBL] [Abstract][Full Text] [Related]
18. Neomycin inhibits glycoprotein C (gC)-dependent binding of herpes simplex virus type 1 to cells and also inhibits postbinding events in entry.
Herold BC; Spear PG
Virology; 1994 Aug; 203(1):166-71. PubMed ID: 8030274
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a hepatitis B and hepatitis delta virus receptor binding site.
Engelke M; Mills K; Seitz S; Simon P; Gripon P; Schnölzer M; Urban S
Hepatology; 2006 Apr; 43(4):750-60. PubMed ID: 16557545
[TBL] [Abstract][Full Text] [Related]
20. Detection of cellular receptors specific for the hepatitis B virus preS surface protein on cell lines of extrahepatic origin.
Park JH; Choi EA; Cho EW; Lee YJ; Park JM; Na SY; Kim KL
Biochem Biophys Res Commun; 2000 Oct; 277(1):246-54. PubMed ID: 11027670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]